Ajooni Biotech Limited reported a total income of 2,603.40 lakhs for Q4 2024, showcasing operational excellence. The company achieved a net profit of 73.02 lakhs, reflecting strategic foresight and efficient…
Spotlight Therapeutics aimed to innovate gene editing by combining CRISPR technology with a cell-specific delivery system similar to antibody-drug conjugates. The company failed to advance its therapies beyond laboratory experiments…
Jade Biosciences is set to present its innovative autoimmune therapies at major biotech conferences in March 2025, with appearances in Boston and Miami. The company will highlight JADE-001, focusing on…
Edesa Biotech focuses on innovation in biotech, particularly in developing the inflammatory treatment paridiprubart. Research and development saw a significant investment increase, exceeding $300,000, highlighting their commitment to healthcare advancements.…
The Federal Trade Commission has updated the Hart-Scott-Rodino Act requirements for mergers, creating a more complex compliance process. This revamped HSR form requires detailed disclosure, probing deeply into the potential…